(Q34466391)

English

Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

1 reference

Europe PubMed Central

Milk thistle for alcoholic and/or hepatitis B or C liver diseases--a systematic cochrane hepato-biliary group review with meta-analyses of randomized clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

1 reference

based on heuristic

inferred from title

Christian Gluud

object named as

Christian Gluud

4

0 references

author name string

Andrea Rambaldi

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Bradly P Jacobs

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Gaetano Iaquinto

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2583-2591

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Prevention by silybin of phalloidin-induced acute hepatoxicity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Biochemical effect of antioxidants on lipids and liver function in experimentally-induced liver damage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Silymarin Retards the Progression of Alcohol-Induced Hepatic Fibrosis in Baboons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

"Negative trials" are positive!

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Milk thistle for the treatment of liver disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Comparison of evidence of treatment effects in randomized and nonrandomized studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Acute, serious drug-induced liver injury

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.00262.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2005.00262.X

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34466391&oldid=2055560886"